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Background. Cardiovascular disease (CVD) mortality varies across racial and ethnic groups in the U.S., and the extent that
known risk factors can explain the differences has not been extensively explored. Methods. We examined the risk of dying
from acute myocardial infarction (AMI) and other heart disease (OHD) among 139,406 African-American (AA), Native Hawaiian
(NH), Japanese-American (JA), Latino and White men and women initially free from cardiovascular disease followed
prospectively between 1993–1996 and 2003 in the Multiethnic Cohort Study (MEC). During this period, 946 deaths from AMI
and 2,323 deaths from OHD were observed. Relative risks of AMI and OHD mortality were calculated accounting for established
CVD risk factors: body mass index (BMI), hypertension, diabetes, smoking, alcohol consumption, amount of vigorous physical
activity, educational level, diet and, for women, type and age at menopause and hormone replacement therapy (HRT) use.
Results. Established CVD risk factors explained much of the observed racial and ethnic differences in risk of AMI and OHD
mortality. After adjustment, NH men and women had greater risks of OHD than Whites (69% excess, P,0.001 and 62% excess,
P=0.003, respectively), and AA women had greater risks of AMI (48% excess, P=0.01) and OHD (35% excess, P=0.007). JA men
had lower risks of AMI (51% deficit, P,0.001) and OHD (27% deficit, P=0.001), as did JA women (AMI, 37% deficit, P=0.03;
OHD, 40% deficit, P=0.001). Latinos had underlying lower risk of AMI death (26% deficit in men and 35% in women, P=0.03).
Conclusion. Known risk factors explain the majority of racial and ethnic differences in mortality due to AMI and OHD. The
unexplained excess in NH and AA and the deficits in JA suggest the presence of unmeasured determinants for cardiovascular
mortality that are distributed unequally across these populations.
Citation: Henderson SO, Haiman CA, Wilkens LR, Kolonel LN, Wan P, et al (2007) Established Risk Factors Account for Most of the Racial Differences in
Cardiovascular Disease Mortality. PLoS ONE 2(4): e377. doi:10.1371/journal.pone.0000377
INTRODUCTION
Cardiovascular disease (CVD), which we define here to exclude
stroke, continues to be one of the most common causes of
mortality worldwide, and, in the U.S., it accounts for more than
a quarter of all deaths. [1,2,3,4] The patterns of cardiovascular
mortality in individual ‘‘racial’’ groups have been examined and
the roles of various risk factors defined. Japanese and Latino
populations have been reported to have a lower than expected
observed prevalence of cardiovascular disease when compared to
Caucasian populations despite a similar, and in some cases
increased, presence of established risk factors such as diabetes and
hypertension. [5,6,7,8]
Even after controlling for the established risk factors of blood
pressure, serum cholesterol, cigarette smoking, and diabetes, African
Americans continued to exhibit higher mortality rates from cardio-
vascular causes when compared to their Caucasian counterparts.
[9,10,11,12,13,14] Native Hawaiians have increased rates of obesity,
a higher prevalence of diabetes, higher serum cholesterol and the
highest cardiovascular mortality rate of any group in Hawaii.
[15,16,17] The overall age- and gender-specific mortality rates due
to heart disease are 66% greater in Native Hawaiians than Cauca-
sians in the state. [18]
Using the Multiethnic Cohort (MEC), a large population-based
study of adult men and women living in Hawaii and California aged
45–75 at recruitment, we have examined the mortality rates from
cardiovascular causes in five racial groups, African Americans (AA),
Native Hawaiians (NH), Japanese Americans (JA), Latinos (LA) and
Whites (W), to specifically address whether the observed differences
in CVD mortality can be explained by differences in the prevalence
of established CVD risk factors.
METHODS
Description of the Cohort
The MEC is a prospective cohort of men and women in Hawaii
and California. The cohort was designed to include the five major
racial groups in Hawaii and California, namely, African Amer-
icans, Native Hawaiians, Japanese Americans, Latinos and
Whites. Small numbers of other ethnic groups are in the cohort
because of the way the cohort was recruited.
In both locations, the MEC was assembled using primarily
drivers’ license files combined with master lists from the
Healthcare Finance Administration. Japanese Americans and
Latinos were targeted by surname using comprehensive comput-
erized lists of Japanese and Spanish surnames from the Census
Bureau supplemented by those maintained by the Hawaii and Los
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cancer registries. African Americans were identified by selecting
census tracts in Los Angeles with a minimum proportion of
individuals (85%) who identified themselves as African Americans
in the 1990 census. Once contacted, individuals self assigned
themselves as African American, Japanese American, Latino,
Native Hawaiian or White. Persons of mixed race were assigned
using the following priority ranking: African American, Native
Hawaiian, Latino, Japanese American and White. It should be
noted that in this cohort, .95% of every racial group, except
Native Hawaiians, reported one group only [19].
The total size of the cohort is over 215,000. For the study
reported here we restricted attention to the participants aged
45–75 at cohort creation in 1993 from the five main racial
groups. We excluded participants who reported a history of
heart attack or angina or stroke (n=16,408) and those with
missing or incomplete questionnaire information on smoking,
diabetes, hypertension, physical activity, weight, height, educa-
tional level or dietary history, thus excluding a further 26,931
individuals. For females we excluded those without known
information on menopausal status and use of menopausal
hormone therapy (n=5,894). Finally we excluded women who
were premenopausal at recruitment (n=13,196). This left 139,406
individuals available for study.
Initial Questionnaire
Upon cohort enrollment, the MEC participants returned a detailed
26-page mail questionnaire that asked about diet (including
alcohol intake), demographic factors, including race/ethnicity,
education, longest held occupation and migrant status, personal
behaviors (e.g., smoking, and physical activity), anthropometry,
dietary history, history of prior medical conditions (e.g., hyperten-
sion, heart attack and cancer), recent medication use (e.g., diuretics
or specific antihypertensive drugs) and for women, reproductive
history and use of exogenous hormones.
Outcome
The cohort members are linked each year to the state death files
for Hawaii and California to ascertain their vital status. Individuals
residing in other states or whose current address is unknown
are linked to the National Death Index file. The status of all
individuals residing in California and Hawaii was ascertained up
to December 31, 2003. The underlying cause of death was
established from the official death certificate and was coded
according to the Ninth Revision of the International Classification
of Disease (ICD-9). Codes of interest were: 410 (acute myocardial
infarction), 411–414 (other acute and subacute forms of ischemic
heart disease, angina pectoris, other forms of chronic ischemic
heart disease), and 425–429 (cardiomyopathy, unspecified cardio-
vascular disease, cardiomegaly, congestive heart failure, myocar-
dial degeneration, and myocarditis). For this analysis, cause of
death was divided into two categories, acute myocardial infarction
(AMI: 410) and all other heart disease (OHD: 411–414, 425–429).
In addition to race and/or ethnicity, the following risk factors
(as reported on the questionnaire) were evaluated in this study:
body mass index (BMI, weight in kg/height in m squared), history
of diabetes, history of hypertension, cigarette smoking status and
pack-years, alcohol intake, amount of vigorous physical activity,
educational level and diet. Vigorous activity included both
vigorous sports and vigorous work. Dietary factors included
saturated fat, unsaturated fat, dietary fiber from fruits, dietary fiber
from grains, dietary fiber from total legumes, omega 3, omega 6,
cholesterol, sodium, folate and isoflavones.
For female subjects, type of and age at menopause and history
of HT use were also evaluated. Women who were continuing to
menstruate naturally (or were on hormonal contraceptives) at the
time of the questionnaire were excluded from this analysis. The
remaining ‘postmenopausal’ women were categorized as having
had a natural menopause or an oophorectomy or a simple
hysterectomy. For the latter two groups of women age at
‘menopause’ was taken as the age at operation, while for
a naturally postmenopausal woman the following schema was
adopted. If she was not taking hormones at the time she stopped
menstruating, age at menopause was taken as her age at this time.
For a woman taking HT before her reported age at last menstrual
period, we set the age of menopause to the age in which she began
HT use (excluding use of progestins alone); with the rationale that
HT use was started because of menopausal symptoms. This is the
same schema to approximate age at menopause as we used in
earlier studies of HRT and endometrial and breast cancer.
[20,21,22]
Statistical Analysis
Hazard ratios, which we report as rate ratios (RRs), for AMI and
OHD mortality were estimated using log-linear proportional
hazard regression models (Cox regression) as implemented in
Procedure stcox in the Stata statistical software package (Stata
Version 8; Stata Corporation, College Station, TX) with the risk
factors categorized considered as categorical variables. The dietary
risk factors described above were evaluated as nutrient densities
separated into quartiles and considered as categorical variables.
Tests for trend for a categorical variable were made as appropriate
scoring the categorical variable as 1, 2, 3, and so on (in these cases
the categorical variable was dropped from the model and replaced
by the trend variable fitted as a linear term). The underlying time
variable in the Cox regression was age (as a continuous variable),
with observation from the date of enrollment to the date of death,
or censoring (date at end of follow-up).
Mortality rates age-standardized to the US Standard Population
ages 45–79 years for the year 1970 were calculated for Whites.
These rates for Whites were then multiplied by the appropriate
rate ratios estimated by the log-linear regression model to estimate
the mortality rates in the other racial groups. These rates are given
to permit the reader to have an idea of the approximate mortality
rates in the different groups. Confidence intervals are given for the
rate ratios as calculated by the log-linear proportional hazard
regression model. Confidence intervals are not given for the
mortality rates as these are only given to help the reader
understand the approximate magnitude of the rates; comparisons
between the racial groups are obtained from the rate ratios.
RESULTS
There were 572 and 1,472 deaths from AMI and OHD respec-
tively among the 70,739 men in the five racial groups (Table 1).
Compared to White males, age-adjusted death rates for AMI were
highest in Native Hawaiians (RR=1.62, P=0.004) and in African
Americans (RR=1.54, P,0.001). The excesses for OHD
mortality of Native-Hawaiian (RR=2.09, P,0.001) and Afri-
can-American (RR=1.66 excess, P,0.001) men were still greater.
In sharp contrast, mortality rates of Japanese-American men were
significantly lower than the rates for Whites for both AMI and
OHD (RR=0.63, P,0.001, and RR=0.75, P,0.001, respec-
tively) while rates for Latino men were similar to those of Whites.
Among the 68,667 women included in this analysis there were
374 deaths due to AMI and 760 due to OHD (Table 1). As was
seen in males, African Americans and Native Hawaiians had the
Cardiac Mortality Risk Factors
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two-fold higher mortality rates than those of Whites for OHD. All
of these differences were statistically highly significant. Japanese-
American women had much lower rates than Whites for both
AMI (RR=0.65, P=0.009) and OHD (RR=0.56, P,0.001)
while rates for Latinos were similar to those of Whites.
Distribution of Established CVD Risk Factors Among
Men
The age-standardized distribution of the risk factors in men in the
different racial groups is shown in Table 2. Obesity (BMI.=30.0)
was least common in Japanese Americans (7.8%), but was 15.5%
in Whites, 19.5% in Latinos, 21.4% in African Americans and
31.8% in Native Hawaiians. Hypertension was reported by
between a third and slightly more than a half of men in the
different ethnic groups from the lowest proportion in Whites
(31.0%), through Latinos (33.2%), Japanese Americans (42.1%)
and Native Hawaiians (48.9%), to the highest proportion in
African Americans (51.9%). Similar large differences were seen for
diabetes; the disease was most frequently reported by African
Americans (13.3%), Native Hawaiians (15.7%) and Latinos
(14.2%), at more than 2.5 times the frequency in Whites (5.4%),
with Japanese Americans at an intermediate frequency (10.4%).
Current smoking was more frequent in the African Americans but
the Native Hawaiians had more current smokers with a greater
than 20 pack-years history. High levels of alcohol intake (.24 g/
day) were seen most commonly in Whites (27.8%), approximately
50–60% more frequently than in the other racial groups. Vigorous
physical activity was reported least often in the African Americans
(65.0%) and most often in the Native Hawaiians (77.6%).
There were increases in risk for both AMI and OHD mortality
in men with low BMI (,23 kg/m
2) and in those with high BMI
(.=35 kg/m
2) (Table 2). Hypertension, diabetes and smoking
were associated with significant increases in both AMI and OHD
mortality. Increasing alcohol intake was associated with a steady
and significant decrease in AMI mortality. Alcohol intake was
clearly associated with decreased OHD mortality, but the evidence
for a dose-response was unclear. Vigorous activity was associated
with significant decreases in mortality from both causes. A
significant inverse association was observed with level of
education, with college graduates having 25% and 24% lower
rates of AMI and OHD mortality, respectively.
The effects of saturated fat were as expected with higher
consumption associated with higher mortality from disease in all
the racial groups. The percentages of calories from saturated fat
were highest in the White, African-American and Latino
populations and dramatically lower in the Japanese-Americans.
Distribution of Established CVD Risk Factors Among
Women
Table 3 shows the age-standardized patterns of risk factors by
racial group for women. Obesity (BMI.=30 kg/m
2) was least
Table 1. Mortality rates from AMI and OHD by race and gender in the MEC.
..................................................................................................................................................
W AA NH JA LA Total
Men
No. of men 18,446 8,981 5,020 21,753 16,539 70,739
AMI: Deaths 143 129 49 125 126 572
Mortality rate
a 60.2 144.4 124.5 38.5 64.4
RR
b 1.00 1.54 1.62 0.63 0.94
(1.22–1.96) (1.17–2.25) (0.49–0.80) (0.74–1.20)
P,0.001 P=0.004 P,0.001 P=0.614
OHD: Deaths 326 319 141 347 339 1,472
Mortality rate
a 124.9 299.7 258.5 79.9 133.6
RR
b 1.00 1.66 2.09 0.75 1.12
(1.42–1.94) (1.71–2.55) (0.65–0.88) (0.96–1.31)
P,0.001 P,0.001 P,0.001 P=0.134
Women
No. of women 17,742 12,241 4,616 20,242 13,826 68,667
AMI: Deaths 77 146 27 68 56 374
Mortality rate
a 21.4 51.3 44.3 13.7 22.9
RR
b 1.00 2.47 1.82 0.65 1.06
(1.87–3.25) (1.17–2.82) (0.47–0.90) (0.75–1.49)
P,0.001 P=0.008 P=0.009 P=0.752
OHD: Deaths 168 269 72 126 125 760
Mortality rate
a 53.8 129.1 111.3 34.4 57.5
RR
b 1.00 2.10 2.17 0.56 1.08
(1.73–2.55) (1.65–2.87) (0.44–0.71) (0.85–1.36)
P,0.001 P,0.001 P,0.001 P=0.532
aPer 100,000 per year, age-standardized to US Standard Population ages 45–79 years for the year 1970. This is calculated for Ws, and the mortality rates for other groups
are computed by multiplying this figure by the racial RRs.
bRate ratios from log-linear proportional hazard regression model (Cox regression; see Statistical Analysis).
doi:10.1371/journal.pone.0000377.t001
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prevalences from 17.0% in Whites to 35.3% in African Americans.
Hypertension was as common as in men. Whites, Japanese
Americans and Latinas reported the lowest proportions of hyperten-
sives (34.6%, 37.9% and 39.1%, respectively), with very high rates in
Native Hawaiians (50.0%) and African Americans (59.4%). Diabetes
also showed the same pattern as in males, with the lowest proportion
reported by Whites (4.9%) and the highest by African Americans,
Native Hawaiians and Latinas (,13.5%). The pattern of smoking by
ethnic group in women was vastly different from that in men.
Approximately two-thirds of Japanese-American and Latino women
had never smoked compared to ,45% of the other ethnic groups.
African American smokers had smoked slightly less than White
smokers. Alcohol use was very uncommon in Japanese-American
females (22.8%), while ,40% of African Americans, Native
Hawaiians and Latinas, and 60.8% of Whites reported drinking,
with the White women drinking more than the other groups.
Hypertension, diabetes and current smoking increased CVD
mortality risk (Table 3), as expected, and this was true in all racial
groups (data not shown). Obesity appeared to have no significant
Table 2. Age-standardized
a distributions of risk factors with associated RRs of mortality from AMI and OHD among men in the MEC.
..................................................................................................................................................
WA A N H J A L A
AMI OHD
M e n %%%% % R R
b PR R
b P
BMI (kg/m
2)
,23 17.4 13.5 10 23.9 10.2 1.35 (1.04–1.77) 1.18 (1.00–1.39)
232 21.6 16.8 12.8 26.1 16.4 1.00 1.00
252 45.5 48.3 45.4 42.2 53.8 0.92 (0.73–1.16) 0.91 (0.78–1.04)
302 12.2 16.5 21.4 6.7 15.6 1.02 (0.75–1.37) 1.01 (0.84–1.22)
.=35 3.3 4.9 10.4 1.1 3.9 1.42 (0.95–2.11) Pt=0.932 1.39 (1.08–1.80) Pt=0.768
Hypertension
c 31.0 51.9 48.9 42.1 33.2 2.29 (1.91–2.74) P,0.001 1.73 (1.55–1.93) P,0.001
Diabetes
c 5.4 13.3 15.7 10.4 14.2 2.17 (1.79–2.63) P,0.001 2.20 (1.95–2.49) P,0.001
Smoking
Never 33.6 26.8 32.3 30.4 34.2 1.00 1.00
Past,=20 packyrs 31.4 34.9 30.9 36.3 39.8 0.98 (0.79–1.22) P=0.862 1.04 (0.90–1.20) P=0.554
Past.20 packyrs 19.0 10.5 16.2 17.3 7.5 1.16 (0.90–1.50) P=0.244 1.45 (1.24–1.71) P,0.001
Current,=20 packyrs 4.8 16.5 7.5 5.9 12.5 1.65 (1.21–2.25) P=0.002 1.89 (1.56–2.30) P,0.001
Current.20 packyrs 11.1 11.3 13.1 10.0 5.9 2.11 (1.60–2.78) P,0.001 2.79 (2.36–3.30) P,0.001
WA A N H J A L A
AMI OHD
Men % % % % % RR P RR P
Alcohol (g eth/d)
0 27.0 40.9 40.5 42.7 33.9 1.00 1.00
.0–12 31.6 32.3 28.5 29.7 38.5 0.81 (0.66–0.98) 0.77 (0.68–0.87)
.12–24 13.5 9.8 10.4 10.7 11.0 0.76 (0.56–1.02) 0.61 (0.49–0.75)
.24 27.8 17.0 20.5 16.9 16.6 0.61 (0.47–0.79) Pt,0.001 0.86 (0.74–1.00) Pt=0.002
Vigorous Physical Activity (hrs/wk)
0 27.1 35.0 22.4 32.8 30.3 1.00 1.00
.0–1.5 14.9 16.6 13.9 18.9 15.1 0.80 (0.63–1.02) 0.82 (0.71–0.95)
.1.5–5.0 24.6 22.9 26.3 24.4 21.9 0.79 (0.63–0.99) 0.79 (0.69–0.91)
.5.0 33.3 25.5 37.3 23.9 32.6 0.61 (0.47–0.79) Pt,0.001 0.72 (0.62–0.83) Pt,0.001
Education
#High school 21.4 37.3 53.1 33.3 62.4 1.00 1.00
Some further educ 28.8 37.9 28.9 31.1 24.5 0.87 (0.71–1.06) 0.97 (0.86–1.09)
College graduate 49.8 24.8 18 35.5 13.1 0.75 (0.59–0.94) Pt=0.010 0.76 (0.65–0.88) Pt=0.001
Percent of calories from saturated fat
,=7.12 20.5 14.3 27.3 41.8 12.9 1.00 1.00
,=8.92 23.7 19.9 28.5 31.1 20.2 1.28 (0.98–1.66) 1.06 (0.90–1.24)
,=10.74 26.5 26.8 26.4 19.1 29.6 1.40 (1.07–1.81) 1.25 (1.07–1.46)
.10.74 29.3 39.0 17.9 8.1 37.3 1.60 (1.23–2.08) Pt=0.001 1.50 (1.28–1.76) Pt,0.001
aAge standardized (5-year age groups) to the total male population included in the study.
bRRs for all risk factors shown estimated simultaneously (i.e. adjusted for each other).
cRRs compared to ‘‘No Hypertension’’, or ‘‘No Diabetes’’.
Abbreviations: eth=ethyl alcohol; Pt=P for trend.
doi:10.1371/journal.pone.0000377.t002
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PLoS ONE | www.plosone.org 4 April 2007 | Issue 4 | e377Table 3. Age-standardized
a distributions of risk factors with associated RRs of mortality from AMI and OHD among women in the
MEC.
..................................................................................................................................................
WA A N H J A L A
AMI OHD
Women % % % % % RR
b PR R
b P
BMI (kg/m
2)
,23 35.0 13.3 19.7 49.0 16 1.01 (0.71–1.44) 1.17 (0.94–1.47)
232,25 19.5 13.9 16.1 21.0 17.8 1.00 1.00
252,30 28.6 37.5 33.9 23.7 39.5 1.05 (0.76–1.45) 0.78 (0.63–0.98)
302,35 11.2 21.9 18.3 5.1 18.4 1.15 (0.79–1.67) 0.79 (0.61–1.03)
.=35 5.8 13.4 12.0 1.2 8.3 1.45 (0.96–2.18) Pt=0.093 1.04 (0.78–1.38) Pt=0.167
Hypertension
c 34.6 59.4 50.0 37.9 39.1 2.55 (1.98–3.27) P,0.001 2.17 (1.84–2.56) P,0.001
Diabetes
c 4.9 13.1 13.6 8.5 13.7 3.25 (2.59–4.09) P,0.001 3.34 (2.84–3.93) P,0.001
Smoking
Never 44.9 45.9 48.1 68.4 66.7 1.00 1.00
Past,=20 packyrs 27.8 28.2 24.2 19.1 21.2 1.06 (0.81–1.39) P=0.673 1.20 (0.99–1.45) P=0.068
Past.20 packyrs 10.7 5.3 8.1 3.3 1.7 1.24 (0.79–1.93) P=0.350 1.99 (1.52–2.60) P,0.001
Current,=20 packyrs 6.0 14.6 11 5.5 8.1 2.44 (1.75–3.40) P,0.001 2.71 (2.16–3.40) P,0.001
Current.20 packyrs 10.6 6.0 8.7 3.7 2.2 3.00 (2.09–4.33) P,0.001 3.18 (2.49–4.07) P,0.001
WA A N H J A L A
AMI OHD
Women % % % % % RR P RR P
Alcohol (g eth/d)
0 39.2 60.9 64.5 77.2 63.8 1.00 1.00
.0–12 37.9 29.8 26.2 19.4 31.0 0.83 (0.64–1.09) 0.77 (0.64–0.93)
.12 22.9 9.3 9.3 3.4 5.3 0.67 (0.44–1.03) Pt=0.038 0.99 (0.77–1.27) Pt=0.212
Vigorous Physical Activity (hrs/wk)
0 52.7 63.3 48.7 63.5 61.6 1.00 1.00
.0–1.5 16.3 17.6 18 16.1 16.2 0.72 (0.52–1.00) 0.81 (0.66–1.01)
.1.5–5.0 16.9 11.9 19.1 13.2 13 0.82 (0.56–1.19) 0.71 (0.54–0.92)
.5.0 14.2 7.2 14.2 7.3 9.1 0.88 (0.56–1.36) Pt=0.156 0.49 (0.34–0.72) Pt,0.001
Education
#High School 30.8 37.2 59.2 40.6 70.9 1.00 1.00
Some further educ 33.8 38.2 26.6 30.5 20.2 0.80 (0.62–1.03) 0.92 (0.77–1.10)
College graduate 35.4 24.6 14.2 28.9 8.9 0.72 (0.53–0.97) Pt=0.017 1.05 (0.86–1.29) Pt=0.832
Menopausal Status
Nat,=44 8.8 9.8 11.6 7.5 13.6 1.00 1.00
Nat 45–49 21.3 16.6 19.8 19.5 22.2 1.02 (0.71–1.47) 0.88 (0.69–1.14)
Nat 50–54 26.2 19.5 23.8 32.9 23.6 0.88 (0.61–1.26) 0.76 (0.60–0.98)
Nat.=55 6.3 5.7 8.0 8.4 5.3 0.65 (0.39–1.07) 0.79 (0.57–1.09)
Ooph,=44 10.1 13 10.3 8.6 8.0 0.76 (0.48–1.21) 0.84 (0.62–1.14)
Ooph 45–49 5.2 5.2 5.5 6.4 3.9 0.71 (0.38–1.34) 0.87 (0.58–1.29)
Ooph.=50 2.8 2.3 3.3 3.1 2.2 1.03 (0.55–1.93) 0.56 (0.33–0.98)
Hyst,=44 14.3 22.2 12.5 9.3 15.9 0.73 (0.48–1.10) 0.68 (0.51–0.90)
Hyst 45–49 3.5 4.2 3.6 2.8 3.6 0.85 (0.47–1.54) 0.88 (0.59–1.31)
Hyst.=50 1.4 1.4 1.7 1.5 1.7 1.14 (0.57–2.27) 0.81 (0.47–1.41)
HT use
c
Never 34.3 54.1 50.0 39.1 52.9 1.00 1.00
Past ET 17.7 20.7 17 13.2 17.2 1.00 (0.85–1.19) P=0.984 1.00 (0.89–1.13) P=0.975
Past PT 4.0 2.5 3.2 2.8 3.3 1.30 (0.55–3.05) P=0.545 0.57 (0.20–1.62) P=0.289
Past EPT 11.8 6.4 7.9 8.6 7.5 0.99 (0.66–1.49) P=0.974 0.97 (0.73–1.28) P=0.815
Current ET 25.1 16.2 17.6 22.3 16.8 0.90 (0.80–1.01) P=0.080 0.89 (0.82–0.97) P=0.006
Current PT 0.6 0.4 0.5 0.8 0.6 0.27 (0.01–8.86) P=0.459 0.61 (0.19–1.98) P=0.405
Current EPT 19.5 5.7 12.0 22.0 9.1 0.97 (0.78–1.21) P=0.807 0.66 (0.52–0.84) P=0.001
Percent of calories from saturated fat
,=6.74 21.3 16.2 24.0 40.0 14.0 1.00 1.00
,=8.49 23.8 21.7 27.7 31.0 20.6 0.83 (0.61–1.12) 1.16 (0.92–1.47)
,=10.32 25.7 26.9 27.8 20.5 28.7 0.97 (0.72–1.30) 1.48 (1.18–1.85)
.10.32 29.2 35.1 20.6 8.2 36.7 0.84 (0.62–1.15) Pt=0.484 1.42 (1.13–1.79) Pt=0.001
aAge standardized (5-year age groups) to the total female population included in the study.
bRRs for all risk factors shown estimated simultaneously (i.e. adjusted for each other).
cRRs compared to ‘‘No Hypertension’’, or ‘‘No Diabetes’’.
dPer 5 years of use.
Abbreviations: eth=ethyl alcohol; Nat=natural menopause; Ooph=oophorectomy; Pt=P for trend.
doi:10.1371/journal.pone.0000377.t003
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PLoS ONE | www.plosone.org 5 April 2007 | Issue 4 | e377effect on mortality except for AMI in those with BMI.=35kg/m
2.
The associations of AMI and OHD with alcohol use were not
straightforward;although the resultspoint to somedegree of reduced
risk in drinkers compared to non-drinkers, there was no evidence of
a dose-response effect. Vigorous activity was associated with a lower
mortality from both AMI and OHD, but only OHD showed a dose-
response relationship. Unlike among men, among women level of
attained education was only associated with a significantly lower
AMI mortality. Although the distribution of the percentage of
calories from saturated fat was similar to men inthat Whites, African
Americans and Latinos had the highest percentage, unlike men,
there was no association between increasing percentage of dietary
calories from saturated fat and mortality from AMI. The association
with OHD mortality remained.
Risk of death from both AMI and OHD showed fairly
consistent steady declines with increasing age at natural meno-
pause (Table 3). There was no particular relationship between age
at oophorectomy or simple hysterectomy and either outcome.
Current ET and EPT use were associated with a significant
decrease in OHD mortality but not in AMI mortality.
Race
Table 4 shows the rate ratios of CVD mortality from AMI and
OHD for men and women for the different racial groups relative
to Whites ‘adjusted’ for age and the non-dietary risk factors shown
in Tables 2 and 3, and additionally for the 11 dietary factors listed
in the Research Design and Methods section above.
Men and AMI: The 54% excess mortality rate in African
Americans and 62% excess in Native Hawaiians largely
disappeared after accounting for the risk factors to a 6% deficit
for African Americans and a 17% excess for Native Hawaiians.
The rates in Japanese Americans and Latinos were reduced
further by adjustment for the risk factors - from 37% to 51% for
Japanese Americans (P,0.001); and from 6% to 26% for Latinos
(P=0.031), when compared to Whites.
Men and OHD: Following adjustment for the risk factors, the
109% excess mortality rate in Native Hawaiians was reduced by
roughly one third to a 69% excess compared to Whites (P,0.001)
whilethe66%excessrateinAfricanAmericanswasreducedtoanon-
significant 15% excess (P=0.105). The mortality rate for Latinos
remaining non-significantly different from Whites, while the 25%
reduced rate in Japanese Americans remained significantly lower
than Whites (P=0.001) following adjustment for the risk factors.
Women and AMI: The 147% excess mortality rate in African
Americans was reduced to a 48% excess (P=0.013) after adjusting
for the risk factors. The 82% excess rate in Native Hawaiians was
similarly reduced to a 24% excess, which was not statistically
significant (P=0.380). Rates for Japanese Americans and Latinos
weresimilarand approximately35%lower than inWhites(P,0.03).
Women and OHD: The large and highly significant 110%
and 117% excess mortality rates in African Americans and Native
Hawaiians were reduced to 35% (P=0.007) and 62% (P=0.003)
excess rates, respectively, after adjusting for the risk factors. The
rate in Latinas remained close to that of Whites after adjustment
while Japanese-American women continued to have significantly
lower rates than White women (40%, P=0.001).
DISCUSSION
In this study we found considerable variation in mortality rates for
AMI and OHD by racial group among both men and women.
Similar to previous reports, the mortality rates for both AMI and
OHD were highest in Native Hawaiians and African Americans
and lowest in Japanese Americans.
The excess cardiovascular mortality in African Americans is well
established. [9,10,11,12,13] Even after controlling for established
risk factors of blood pressure, serum cholesterol, cigarette smoking,
and diabetes, African Americans continued to exhibit higher
mortality rates from cardiovascular causes when compared to their
Caucasian counterparts. [12,13,14] In this cohort the African
Americans’ excess rates persisted in women but not in men.
In the few studies comparing Native Hawaiians to non-
Hawaiians, Native Hawaiians have exhibited up to a 44% higher
mortality rate from cardiovascular disease. [16,23] Diabetes,
obesity, the Insulin Resistance Syndrome, and hypertension are
the risk factors most commonly cited as contributing to their excess
cardiovascular deaths. [21,22]
Finally, the Japanese have consistently demonstrated lower rates
of cardiovascular mortality when compared to White populations.
[6,8,24,25] These findings persist despite higher rates of hyperten-
sion and smoking prevalence among Japanese populations. [8]
In this cohort, diabetes and hypertension were the most
important risk factors for the increased AMI and OHD mortality
in Native-Hawaiian and African-American men with smoking also
contributing to their high rates. These factors, in fact, suffice to
‘explain’ the high rate of AMI mortality in African-American men
and explained most of their excess of OHD. These factors also
explained a significant proportion of the excess mortality from
AMI and OHD in Native-Hawaiian men, but an excess mortality
rate, for OHD in particular (69% excess), still remained when
compared to Whites. Diabetes and hypertension were also the
most important risk factors for AMI and OHD mortality in Native
Hawaiian and African-American women with lower use of HRT
also contributing to their increased rates but to a much lesser
extent (see below). These factors explained a significant proportion
of the excess mortality from AMI and OHD in Native-Hawaiian
and African-American women, but substantial excesses remained
for both AMI and OHD.
In contrast, the decreased mortality rates in Japanese men and
women were not explained at all by the risk factors we studied,
while Latinos, who have a lower prevalence of risk factors, had
rates that were modestly lower than Whites in the multivariate
adjusted model.
There was a substantial reduction in OHD mortality in women
among current users of ET and of EPT in all racial groups (data
not shown) and no reduction in AMI mortality. In the Women’s
Health Initiative (WHI) clinical trial of ET, there was a reduction
in risk of CVD incidence in agreement with the results we
observed, but in the WHI trial of EPT, there was an increased risk
of AMI in apparent contradiction both to the results we observed
and to the beneficial effects seen in observational case-control and
cohort studies. [26,27] In the WHI EPT trial, there was
a reduction in AMI in those women who started taking EPT in
the trial within 10 years of menopause; it was only in the women
who started EPT 10 years or more after menopause that an
increased risk was seen. [26] Further RCT are needed to firmly
establish whether this ‘‘time from menopause’’ effect is real.
In men and women in this cohort, the protective effect of
alcohol consumption was seen in all racial groups (data not
shown), findings consistent with those reported by others.
[28,29,30] In the MEC, the protective effect of alcohol was not
dependent on the type of alcohol (red wine, beer, grain alcohol)
consumed. While our results demonstrate an essentially linear
decrease in AMI and OHD mortality with increasing alcohol
consumption, there have been other reports indicating that this
decreasing trend eventually begins to reverse. [28,30] It is possible
that alcohol consumption was too infrequent in the MEC to study
this phenomenon. Alcohol was also associated with a significant
Cardiac Mortality Risk Factors
PLoS ONE | www.plosone.org 6 April 2007 | Issue 4 | e377and consistent decrease in mortality from more chronic forms of
heart disease (OHD) in all the racialities studied.
The relationship between physical activity and the risk of CVD
has been well described in the past. [31,32,33,34,35] As was seen
in this cohort, there appears to be an inverse relationship between
physical activity and risk of cardiovascular death, a relationship
that is linear to a point after which the risk may increase. [33,35]
The number of men in the ‘‘.5 hour/week’’ for vigorous activity
is higher than previously described as we combined vigorous work
with sporting activities. Women demonstrate a more typical
distribution. We examined vigorous physical activity specifically as
such activity has been associated more often with measurable
benefit as opposed to so-called non-conditioning activities such as
walking.
Table 4. Observed and adjusted rate ratios (RRs) of death from AMI and OHD by race and gender in the MEC.
..................................................................................................................................................
WA A N H J A L A
Men
AMI
RR 1.00 1.54 1.62 0.63 0.94
(1.22–1.96) (1.17–2.25) (0.49–0.80) (0.74–1.20)
P,0.001 P=0.004 P,0.001 P=0.614
RR adjusted for risk factors 1.00 0.98 1.08 0.45 0.74
(0.76–1.26) (0.77–1.52) (0.35–0.58) (0.57–0.96)
P=0.884 P=0.651 P,0.001 P=0.022
RR adjusted for risk factors & diet 1.00 0.94 1.17 0.49 0.74
(0.73–1.22) (0.81–1.67) (0.36–0.67) (0.56–0.97)
P=0.661 P=0.403 P,0.001 P=0.031
OHD
RR 1.00 1.66 2.09 0.75 1.12
(1.42–1.94) (1.71–2.55) (0.65–0.88) (0.96–1.31)
P,0.001 P,0.001 P,0.001 P=0.134
RR adjusted for risk factors 1.00 1.16 1.50 0.60 0.96
(0.99–1.37) (1.22–1.84) (0.51–0.70) (0.81–1.13)
P=0.068 P,0.001 P,0.001 P=0.616
RR adjusted for risk factors & diet 1.00 1.15 1.69 0.73 0.90
(0.97–1.35) (1.36–2.11) (0.61–0.89) (0.76–1.08)
P=0.105 P,0.001 P=0.001 P=0.264
Women
AMI
RR 1.00 2.47 1.82 0.65 1.06
(1.87–3.25) (1.17–2.82) (0.47–0.90) (0.75–1.49)
P,0.001 P=0.008 P=0.009 P=0.752
RR adjusted for risk factors 1.00 1.45 1.13 0.57 0.72
(1.07–1.95) (0.72–1.77) (0.40–0.81) (0.50–1.04)
P=0.015 P=0.600 P=0.002 P=0.081
RR adjusted for risk factors & diet 1.00 1.48 1.24 0.63 0.65
(1.09–2.01) (0.77–2.01) (0.41–0.96) (0.44–0.96)
P=0.013 P=0.380 P=0.034 P=0.032
OHD
RR 1.00 2.10 2.17 0.56 1.08
(1.73–2.55) (1.65–2.87) (0.44–0.71) (0.85–1.36)
P,0.001 P,0.001 P,0.001 P=0.532
RR adjusted for risk factors 1.00 1.41 1.60 0.53 0.93
(1.14–1.73) (1.20–2.13) (0.41–0.68) (0.72–1.20)
P=0.001 P=0.001 P,0.001 P=0.584
RR adjusted for risk factors & diet 1.00 1.35 1.62 0.60 0.88
(1.09–1.67) (1.18–2.21) (0.44–0.81) (0.67–1.15)
P=0.007 P=0.003 P=0.001 P=0.359
doi:10.1371/journal.pone.0000377.t004
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PLoS ONE | www.plosone.org 7 April 2007 | Issue 4 | e377Elevated lipid levels is a marker of CVD risk and previous
studies have shown Japanese Americans to have a more favorable
lipid profile than Native Hawaiians which might contribute to
their decreased cardiovascular mortality. [8,36] In contrast,
multiple studies in African Americans have not demonstrated
lipid profiles to be different than those of Whites, and therefore
does not explain their increased cardiovascular mortality.
[37,38,39] While we were unable to assess individual lipid levels
in the present study, when the data was adjusted for intake of
dietary saturated fat (as a percentage of their total caloric intake),
there were only minor changes in AMI and OHD relative
mortality rates.
In previous studies, socioeconomic status (SES) as measured by
median income has been shown to partially explain differences in
CVD mortality between African Americans and Whites, with poor
living conditions and limited access to health care experienced by
those in lower socioeconomic strata hypothesized to be responsible
for the majority of the excess mortality between these populations.
[9,40] Our study used attained education as a proxy for SES and
found that having a higher educational level was associated with
significantly reduced risks of AMI and OHD in men, and with
a slightly reduced risk of AMI in women. The adjusted results
shown in Table 4 include adjustment for educational level, which
varies considerably between the racial groups. We also classified
the cohort residing in Los Angeles County (mainly African
Americans and Latinos) by SES based on their census tract of
residence at the time of initial questionnaire to confirm that
educational level was a suitable proxy for SES and the two were
highly correlated across both groups. However, neither educa-
tional level nor SES as measured by census tract of residence was
associated with the excess risk of death due to AMI or OHD in
African Americans.
One apparent limitation of this study is the possibility that the
use of a recall of a diagnosis of hypertension in the cohort will
result in an underestimation of the extent that blood pressure
differences can account for mortality differences. In fact, when
compared to other published data [17,41] the prevalence of
hypertension in the MEC is much higher for Whites, African
Americans, Native Hawaiians and Latinos than previously
reported. Therefore we do not believe we are underestimating
the prevalence nor the differences between racial and racial groups
as both are higher than reported elsewhere.
In summary, we found that traditional risk factors explain the
majority of the differences in mortality due to AMI and OHD
among these five groups. After adjustment there remained
significant excess in mortality due to AMI and OHD in African-
American women, and OHD in Native-Hawaiian men and
women. There was also a lower than expected mortality from AMI
and OHD in Japanese-American men and women, and of AMI in
Latino men and women compared to Whites. For these groups
there appear to be unmeasured environmental factors, social or
cultural factors, or genetic risk factors for cardiovascular mortality
that are distributed unequally across these populations.
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